English

MEDIFAST, INC.

EDGAR

MED Quarterly report (10-Q) · filed 2026-10-26

Annual consolidated revenue for 2025: about USD 385.8M, using the latest reported figures. The previous period, 2024, was about USD 602.5M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

72 million USD

2026 Q3 · USD

Exact inputs and evidence

Revenue: 72048000 USD Source

Operating margin

-26.87%

2026 Q3 · %

Exact inputs and evidence

Operating Income: -19358000 USD Source
Revenue: 72048000 USD Source

Operating cash flow

3.3 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 5252000 USD Source
Operating Cash Flow: 1957000 USD Source

Free cash flow

2.87 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 5252000 USD Source
Operating Cash Flow: 1957000 USD Source
Capital Expenditure: 2492000 USD Source
Capital Expenditure: 2065000 USD Source

Cash and cash equivalents: 58.4 million USD 2026-09-30 Source
Exact value

58372000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 11.2 million shares 2026-09-30 Source
Exact value

11183000 shares

Reported share-count change

1.75% · 192 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

10991000 shares · 2025-09-30· Source
11183000 shares · 2026-09-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-26.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2025-12-31
Operating income: 8 of 11 periods available· newest 2025-12-31
Net income: 8 of 11 periods available· newest 2025-12-31
Operating cash flow: 8 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2025-12-31
Total assets: 7 of 11 periods available· newest 2025-12-31
Total liabilities: 7 of 11 periods available· newest 2025-12-31
Current assets: 7 of 11 periods available· newest 2025-12-31
Current liabilities: 7 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-36%

Prior period

USD 602.46 million

2024-01-01 – 2024-12-31
Current period

USD 385.79 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

385788000 − 602463000 = -216675000 USD

602463000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
385788000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MEDIFAST, INC. · 2025-12-31 MEDIFAST, INC. (edgar:910329) Year-over-year change in Revenue: -216675000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 385788000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#526508 Filing: 000162828026008656 Input fundies:Revenue: 602463000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#527230 Filing: 000162828026008656
The citation records this snapshot. The page link may show a newer release later.
Net income
-993%

Prior period

USD 2.09 million

2024-01-01 – 2024-12-31
Current period

−USD 18.67 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-18672000 − 2091000 = -20763000 USD

2091000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-18672000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MEDIFAST, INC. · 2025-12-31 MEDIFAST, INC. (edgar:910329) Year-over-year change in Net income: -20763000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -18672000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#1323603 Filing: 000162828026008656 Input fundies:NetIncome: 2091000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#1324542 Filing: 000162828026008656
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-72%

Prior period

USD 24.48 million

2024-01-01 – 2024-12-31
Current period

USD 6.86 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

6863000 − 24476000 = -17613000 USD

24476000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
6863000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MEDIFAST, INC. · 2025-12-31 MEDIFAST, INC. (edgar:910329) Year-over-year change in Operating cash flow: -17613000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 6863000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#648547 Filing: 000162828026008656 Input fundies:OperatingCashFlow: 24476000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#649066 Filing: 000162828026008656
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-24.7%

Prior period

USD 7.45 million

2024-01-01 – 2024-12-31
Current period

USD 5.61 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

5614000 − 7454000 = -1840000 USD

7454000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
5614000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MEDIFAST, INC. · 2025-12-31 MEDIFAST, INC. (edgar:910329) Year-over-year change in Capital expenditure: -1840000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 5614000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#654882 Filing: 000162828026008656 Input fundies:CapitalExpenditure: 7454000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#655377 Filing: 000162828026008656
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 385.79 million 100% of revenue
Cost of revenue USD 110.6 million 29% of revenue
Operating expenses USD 293.7 million 76% of revenue
Other operating costs Derived −USD 4.3 million −1.1% of revenue
Operating income −USD 14.21 million −3.7% of revenue
Tax, interest and other Derived USD 4.46 million 1.2% of revenue
Net income −USD 18.67 million −4.8% of revenue

Cash

Operating cash flow USD 6.86 million 1.8% of revenue
Capital expenditure USD 5.61 million 1.5% of revenue
Free cash flow Derived USD 1.25 million 0.3% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 89%
2021 11%86%
2022 88%
2023 9.3%88%
2024 100%
2025 Operating loss: operating costs were 104% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	272773000	244089000 Derived	28684000	8626000 Derived	20058000	26592000 Derived	Source 2015-01-01 – 2015-12-31: 272773000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: 28684000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: 20058000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 29411000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 2819000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	1526087000	1309846000 Derived	216241000	52210000 Derived	164031000	60336000 Derived	Source 2021-01-01 – 2021-12-31: 1526087000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 216241000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 164031000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 94545000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 34209000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	1598577000	1413771000 Derived	184806000	41238000 Derived	143568000	177889000 Derived	Source 2022-01-01 – 2022-12-31: 1598577000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 184806000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 143568000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 194570000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 16681000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	1072054000	945652000 Derived	126402000	26987000 Derived	99415000	141174000 Derived	Source 2023-01-01 – 2023-12-31: 1072054000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: 126402000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: 99415000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 147657000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 6483000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	602463000	599585000 Derived	2878000	787000 Derived	2091000	17022000 Derived	Source 2024-01-01 – 2024-12-31: 602463000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: 2878000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 2091000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 24476000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 7454000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	385788000	400001000 Derived	-14213000	4459000 Derived	-18672000	1249000 Derived	Source 2025-01-01 – 2025-12-31: 385788000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -14213000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -18672000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 6863000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 5614000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 385.8M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	272773000	Revenue: 272773000 Open source
20212021-12-31	Revenue	1526087000	Revenue: 1526087000 Open source
20222022-12-31	Revenue	1598577000	Revenue: 1598577000 Open source
20232023-12-31	Revenue	1072054000	Revenue: 1072054000 Open source
20242024-12-31	Revenue	602463000	Revenue: 602463000 Open source
20252025-12-31	Revenue	385788000	Revenue: 385788000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-36% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 272773000 Open source
20212021-12-31	Year over year	No prior comparable period	Revenue: 1526087000 Open source
20222022-12-31	Year over year	4.8%	Revenue: 1598577000 Open source Revenue: 1526087000 Open source
20232023-12-31	Year over year	-32.9%	Revenue: 1072054000 Open source Revenue: 1598577000 Open source
20242024-12-31	Year over year	-43.8%	Revenue: 602463000 Open source Revenue: 1072054000 Open source
20252025-12-31	Year over year	-36%	Revenue: 385788000 Open source Revenue: 602463000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -3.7% 2025

Net margin -4.8% 2025

Free cash flow margin 0.3% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	10.5%	Operating Income: 28684000 Open source Revenue: 272773000 Open source
20212021-12-31	Operating margin	14.2%	Operating Income: 216241000 Open source Revenue: 1526087000 Open source
20222022-12-31	Operating margin	11.6%	Operating Income: 184806000 Open source Revenue: 1598577000 Open source
20232023-12-31	Operating margin	11.8%	Operating Income: 126402000 Open source Revenue: 1072054000 Open source
20242024-12-31	Operating margin	0.5%	Operating Income: 2878000 Open source Revenue: 602463000 Open source
20252025-12-31	Operating margin	-3.7%	Operating Income: -14213000 Open source Revenue: 385788000 Open source
20152015-12-31	Net margin	7.4%	Net Income: 20058000 Open source Revenue: 272773000 Open source
20212021-12-31	Net margin	10.7%	Net Income: 164031000 Open source Revenue: 1526087000 Open source
20222022-12-31	Net margin	9%	Net Income: 143568000 Open source Revenue: 1598577000 Open source
20232023-12-31	Net margin	9.3%	Net Income: 99415000 Open source Revenue: 1072054000 Open source
20242024-12-31	Net margin	0.3%	Net Income: 2091000 Open source Revenue: 602463000 Open source
20252025-12-31	Net margin	-4.8%	Net Income: -18672000 Open source Revenue: 385788000 Open source
20152015-12-31	Free cash flow margin	9.7%	Revenue: 272773000 Open source Operating Cash Flow: 29411000 Open source Capital Expenditure: 2819000 Open source
20212021-12-31	Free cash flow margin	4%	Revenue: 1526087000 Open source Operating Cash Flow: 94545000 Open source Capital Expenditure: 34209000 Open source
20222022-12-31	Free cash flow margin	11.1%	Revenue: 1598577000 Open source Operating Cash Flow: 194570000 Open source Capital Expenditure: 16681000 Open source
20232023-12-31	Free cash flow margin	13.2%	Revenue: 1072054000 Open source Operating Cash Flow: 147657000 Open source Capital Expenditure: 6483000 Open source
20242024-12-31	Free cash flow margin	2.8%	Revenue: 602463000 Open source Operating Cash Flow: 24476000 Open source Capital Expenditure: 7454000 Open source
20252025-12-31	Free cash flow margin	0.3%	Revenue: 385788000 Open source Operating Cash Flow: 6863000 Open source Capital Expenditure: 5614000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 6.9M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	29411000	Operating Cash Flow: 29411000 Open source
20212021-12-31	Operating cash flow	94545000	Operating Cash Flow: 94545000 Open source
20222022-12-31	Operating cash flow	194570000	Operating Cash Flow: 194570000 Open source
20232023-12-31	Operating cash flow	147657000	Operating Cash Flow: 147657000 Open source
20242024-12-31	Operating cash flow	24476000	Operating Cash Flow: 24476000 Open source
20252025-12-31	Operating cash flow	6863000	Operating Cash Flow: 6863000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 1.2M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	26592000	Operating Cash Flow: 29411000 Open source Capital Expenditure: 2819000 Open source
20212021-12-31	Free cash flow	60336000	Operating Cash Flow: 94545000 Open source Capital Expenditure: 34209000 Open source
20222022-12-31	Free cash flow	177889000	Operating Cash Flow: 194570000 Open source Capital Expenditure: 16681000 Open source
20232023-12-31	Free cash flow	141174000	Operating Cash Flow: 147657000 Open source Capital Expenditure: 6483000 Open source
20242024-12-31	Free cash flow	17022000	Operating Cash Flow: 24476000 Open source Capital Expenditure: 7454000 Open source
20252025-12-31	Free cash flow	1249000	Operating Cash Flow: 6863000 Open source Capital Expenditure: 5614000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

19.8% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	24.5%	Total Liabilities: 28742000 Open source Total Assets: 117326000 Open source
20212021-12-31	Liabilities / assets	49.2%	Total Liabilities: 195852000 Open source Total Assets: 398326000 Open source
20222022-12-31	Liabilities / assets	51%	Total Liabilities: 161169000 Open source Total Assets: 316213000 Open source
20232023-12-31	Liabilities / assets	35%	Total Liabilities: 108427000 Open source Total Assets: 309908000 Open source
20242024-12-31	Liabilities / assets	26.1%	Total Liabilities: 74104000 Open source Total Assets: 284213000 Open source
20252025-12-31	Liabilities / assets	19.8%	Total Liabilities: 49053000 Open source Total Assets: 247973000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.69× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	3.74×	Current Assets: 88073000 Open source Current Liabilities: 23564000 Open source
20212021-12-31	Current assets / current liabilities	1.81×	Current Assets: 306866000 Open source Current Liabilities: 169832000 Open source
20222022-12-31	Current assets / current liabilities	1.58×	Current Assets: 222784000 Open source Current Liabilities: 140894000 Open source
20232023-12-31	Current assets / current liabilities	2.43×	Current Assets: 224029000 Open source Current Liabilities: 92300000 Open source
20242024-12-31	Current assets / current liabilities	3.34×	Current Assets: 214404000 Open source Current Liabilities: 64161000 Open source
20252025-12-31	Current assets / current liabilities	4.69×	Current Assets: 201683000 Open source Current Liabilities: 42962000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	USD 20.06 million Exact value Exact value: 20058000 USD 2015-01-01 – 2015-12-31: 20058000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIFAST, INC. · 2015-12-31 MEDIFAST, INC. (edgar:910329) Net Income: 20058000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: 20058000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000114420416088200/med-20151231.xml#94756 Filing: 000114420416088200 The citation records this snapshot. The page link may show a newer release later.	USD 29.41 million Exact value Exact value: 29411000 USD 2015-01-01 – 2015-12-31: 29411000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIFAST, INC. · 2015-12-31 MEDIFAST, INC. (edgar:910329) Operating Cash Flow: 29411000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 29411000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000114420416088200/med-20151231.xml#110707 Filing: 000114420416088200 The citation records this snapshot. The page link may show a newer release later.	USD 2.82 million Exact value Exact value: 2819000 USD 2015-01-01 – 2015-12-31: 2819000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIFAST, INC. · 2015-12-31 MEDIFAST, INC. (edgar:910329) Capital Expenditure: 2819000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2819000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000114420416088200/med-20151231.xml#106839 Filing: 000114420416088200 The citation records this snapshot. The page link may show a newer release later.	USD 26.59 million Calculation and evidence 29411000 − 2819000 USD Exact free cash flow: 26592000 USD 2015-01-01 – 2015-12-31: 29411000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 2819000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIFAST, INC. · 2015-12-31 MEDIFAST, INC. (edgar:910329) Free cash flow: 26592000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 29411000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000114420416088200/med-20151231.xml#110707 Filing: 000114420416088200 Input fundies:CapitalExpenditure: 2819000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000114420416088200/med-20151231.xml#106839 Filing: 000114420416088200 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	USD 77.92 million Exact value Exact value: 77916000 USD 2019-01-01 – 2019-12-31: 77916000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIFAST, INC. · 2019-12-31 MEDIFAST, INC. (edgar:910329) Net Income: 77916000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 77916000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828022003534/med-20211231.htm#1090250 Filing: 000162828022003534 The citation records this snapshot. The page link may show a newer release later.	USD 84.26 million Exact value Exact value: 84261000 USD 2019-01-01 – 2019-12-31: 84261000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIFAST, INC. · 2019-12-31 MEDIFAST, INC. (edgar:910329) Operating Cash Flow: 84261000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 84261000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828022003534/med-20211231.htm#757814 Filing: 000162828022003534 The citation records this snapshot. The page link may show a newer release later.	USD 10.06 million Exact value Exact value: 10058000 USD 2019-01-01 – 2019-12-31: 10058000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIFAST, INC. · 2019-12-31 MEDIFAST, INC. (edgar:910329) Capital Expenditure: 10058000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10058000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828022003534/med-20211231.htm#765433 Filing: 000162828022003534 The citation records this snapshot. The page link may show a newer release later.	USD 74.2 million Calculation and evidence 84261000 − 10058000 USD Exact free cash flow: 74203000 USD 2019-01-01 – 2019-12-31: 84261000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 10058000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIFAST, INC. · 2019-12-31 MEDIFAST, INC. (edgar:910329) Free cash flow: 74203000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 84261000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828022003534/med-20211231.htm#757814 Filing: 000162828022003534 Input fundies:CapitalExpenditure: 10058000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828022003534/med-20211231.htm#765433 Filing: 000162828022003534 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 102.86 million Exact value Exact value: 102859000 USD 2020-01-01 – 2020-12-31: 102859000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIFAST, INC. · 2020-12-31 MEDIFAST, INC. (edgar:910329) Net Income: 102859000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 102859000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828023004341/med-20221231.htm#1092147 Filing: 000162828023004341 The citation records this snapshot. The page link may show a newer release later.	USD 145.2 million Exact value Exact value: 145196000 USD 2020-01-01 – 2020-12-31: 145196000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIFAST, INC. · 2020-12-31 MEDIFAST, INC. (edgar:910329) Operating Cash Flow: 145196000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 145196000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828023004341/med-20221231.htm#773908 Filing: 000162828023004341 The citation records this snapshot. The page link may show a newer release later.	USD 5.89 million Exact value Exact value: 5887000 USD 2020-01-01 – 2020-12-31: 5887000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIFAST, INC. · 2020-12-31 MEDIFAST, INC. (edgar:910329) Capital Expenditure: 5887000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5887000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828023004341/med-20221231.htm#781031 Filing: 000162828023004341 The citation records this snapshot. The page link may show a newer release later.	USD 139.31 million Calculation and evidence 145196000 − 5887000 USD Exact free cash flow: 139309000 USD 2020-01-01 – 2020-12-31: 145196000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 5887000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIFAST, INC. · 2020-12-31 MEDIFAST, INC. (edgar:910329) Free cash flow: 139309000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 145196000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828023004341/med-20221231.htm#773908 Filing: 000162828023004341 Input fundies:CapitalExpenditure: 5887000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828023004341/med-20221231.htm#781031 Filing: 000162828023004341 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 164.03 million Exact value Exact value: 164031000 USD 2021-01-01 – 2021-12-31: 164031000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIFAST, INC. · 2021-12-31 MEDIFAST, INC. (edgar:910329) Net Income: 164031000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 164031000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828024005620/med-20231231.htm#945791 Filing: 000162828024005620 The citation records this snapshot. The page link may show a newer release later.	USD 94.55 million Exact value Exact value: 94545000 USD 2021-01-01 – 2021-12-31: 94545000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIFAST, INC. · 2021-12-31 MEDIFAST, INC. (edgar:910329) Operating Cash Flow: 94545000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 94545000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828024005620/med-20231231.htm#717598 Filing: 000162828024005620 The citation records this snapshot. The page link may show a newer release later.	USD 34.21 million Exact value Exact value: 34209000 USD 2021-01-01 – 2021-12-31: 34209000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIFAST, INC. · 2021-12-31 MEDIFAST, INC. (edgar:910329) Capital Expenditure: 34209000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 34209000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828024005620/med-20231231.htm#723918 Filing: 000162828024005620 The citation records this snapshot. The page link may show a newer release later.	USD 60.34 million Calculation and evidence 94545000 − 34209000 USD Exact free cash flow: 60336000 USD 2021-01-01 – 2021-12-31: 94545000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 34209000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIFAST, INC. · 2021-12-31 MEDIFAST, INC. (edgar:910329) Free cash flow: 60336000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 94545000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828024005620/med-20231231.htm#717598 Filing: 000162828024005620 Input fundies:CapitalExpenditure: 34209000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828024005620/med-20231231.htm#723918 Filing: 000162828024005620 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 143.57 million Exact value Exact value: 143568000 USD 2022-01-01 – 2022-12-31: 143568000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIFAST, INC. · 2022-12-31 MEDIFAST, INC. (edgar:910329) Net Income: 143568000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 143568000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828025006094/med-20241231.htm#1348515 Filing: 000162828025006094 The citation records this snapshot. The page link may show a newer release later.	USD 194.57 million Exact value Exact value: 194570000 USD 2022-01-01 – 2022-12-31: 194570000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIFAST, INC. · 2022-12-31 MEDIFAST, INC. (edgar:910329) Operating Cash Flow: 194570000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 194570000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828025006094/med-20241231.htm#723112 Filing: 000162828025006094 The citation records this snapshot. The page link may show a newer release later.	USD 16.68 million Exact value Exact value: 16681000 USD 2022-01-01 – 2022-12-31: 16681000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIFAST, INC. · 2022-12-31 MEDIFAST, INC. (edgar:910329) Capital Expenditure: 16681000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16681000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828025006094/med-20241231.htm#729456 Filing: 000162828025006094 The citation records this snapshot. The page link may show a newer release later.	USD 177.89 million Calculation and evidence 194570000 − 16681000 USD Exact free cash flow: 177889000 USD 2022-01-01 – 2022-12-31: 194570000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 16681000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIFAST, INC. · 2022-12-31 MEDIFAST, INC. (edgar:910329) Free cash flow: 177889000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 194570000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828025006094/med-20241231.htm#723112 Filing: 000162828025006094 Input fundies:CapitalExpenditure: 16681000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828025006094/med-20241231.htm#729456 Filing: 000162828025006094 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	USD 99.42 million Exact value Exact value: 99415000 USD 2023-01-01 – 2023-12-31: 99415000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIFAST, INC. · 2023-12-31 MEDIFAST, INC. (edgar:910329) Net Income: 99415000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: 99415000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#1325476 Filing: 000162828026008656 The citation records this snapshot. The page link may show a newer release later.	USD 147.66 million Exact value Exact value: 147657000 USD 2023-01-01 – 2023-12-31: 147657000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIFAST, INC. · 2023-12-31 MEDIFAST, INC. (edgar:910329) Operating Cash Flow: 147657000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 147657000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#649586 Filing: 000162828026008656 The citation records this snapshot. The page link may show a newer release later.	USD 6.48 million Exact value Exact value: 6483000 USD 2023-01-01 – 2023-12-31: 6483000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIFAST, INC. · 2023-12-31 MEDIFAST, INC. (edgar:910329) Capital Expenditure: 6483000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6483000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#655872 Filing: 000162828026008656 The citation records this snapshot. The page link may show a newer release later.	USD 141.17 million Calculation and evidence 147657000 − 6483000 USD Exact free cash flow: 141174000 USD 2023-01-01 – 2023-12-31: 147657000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 6483000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIFAST, INC. · 2023-12-31 MEDIFAST, INC. (edgar:910329) Free cash flow: 141174000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 147657000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#649586 Filing: 000162828026008656 Input fundies:CapitalExpenditure: 6483000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#655872 Filing: 000162828026008656 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	USD 2.09 million Exact value Exact value: 2091000 USD 2024-01-01 – 2024-12-31: 2091000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIFAST, INC. · 2024-12-31 MEDIFAST, INC. (edgar:910329) Net Income: 2091000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2091000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#1324542 Filing: 000162828026008656 The citation records this snapshot. The page link may show a newer release later.	USD 24.48 million Exact value Exact value: 24476000 USD 2024-01-01 – 2024-12-31: 24476000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIFAST, INC. · 2024-12-31 MEDIFAST, INC. (edgar:910329) Operating Cash Flow: 24476000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 24476000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#649066 Filing: 000162828026008656 The citation records this snapshot. The page link may show a newer release later.	USD 7.45 million Exact value Exact value: 7454000 USD 2024-01-01 – 2024-12-31: 7454000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIFAST, INC. · 2024-12-31 MEDIFAST, INC. (edgar:910329) Capital Expenditure: 7454000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7454000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#655377 Filing: 000162828026008656 The citation records this snapshot. The page link may show a newer release later.	USD 17.02 million Calculation and evidence 24476000 − 7454000 USD Exact free cash flow: 17022000 USD 2024-01-01 – 2024-12-31: 24476000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 7454000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIFAST, INC. · 2024-12-31 MEDIFAST, INC. (edgar:910329) Free cash flow: 17022000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 24476000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#649066 Filing: 000162828026008656 Input fundies:CapitalExpenditure: 7454000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#655377 Filing: 000162828026008656 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 18.67 million Exact value Exact value: -18672000 USD 2025-01-01 – 2025-12-31: -18672000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIFAST, INC. · 2025-12-31 MEDIFAST, INC. (edgar:910329) Net Income: -18672000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18672000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#1323603 Filing: 000162828026008656 The citation records this snapshot. The page link may show a newer release later.	USD 6.86 million Exact value Exact value: 6863000 USD 2025-01-01 – 2025-12-31: 6863000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIFAST, INC. · 2025-12-31 MEDIFAST, INC. (edgar:910329) Operating Cash Flow: 6863000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6863000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#648547 Filing: 000162828026008656 The citation records this snapshot. The page link may show a newer release later.	USD 5.61 million Exact value Exact value: 5614000 USD 2025-01-01 – 2025-12-31: 5614000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIFAST, INC. · 2025-12-31 MEDIFAST, INC. (edgar:910329) Capital Expenditure: 5614000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5614000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#654882 Filing: 000162828026008656 The citation records this snapshot. The page link may show a newer release later.	USD 1.25 million Calculation and evidence 6863000 − 5614000 USD Exact free cash flow: 1249000 USD 2025-01-01 – 2025-12-31: 6863000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 5614000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIFAST, INC. · 2025-12-31 MEDIFAST, INC. (edgar:910329) Free cash flow: 1249000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/910329?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6863000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#648547 Filing: 000162828026008656 Input fundies:CapitalExpenditure: 5614000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm#654882 Filing: 000162828026008656 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

182 filings · 7,921 latest values · 7,921 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000910329, 910329, MED, edgar:910329, med

Also known as HEALTHRITE INC, MEDIFAST INC, MEDIFAST, INC., Medifast, Inc., Medifast, Inc.

MEDIFAST, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation